---
document_datetime: 2023-09-21 19:00:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/nyxoid-epar-all-authorised-presentations_en.pdf
document_name: nyxoid-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6795032
conversion_datetime: 2025-12-27 14:41:26.04789
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size          |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|--------------------|
| EU/1/17/1238/001 | Nyxoid            | 1.8 mg     | Nasal spray, solution | Nasal use                 | vial (glass)          | 0.1 ml                    | 2 spray containers |